Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
The company does not expect this development to have any material impact on the current business operations
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
Lonza to develop spray-dried formulations for an intranasally-delivered biologic for Iconovo at its Center of Excellence for bioavailability enhancement and inhaled delivery in Bend (US)
Agreement further expands Aptar Pharma’s leading respiratory portfolio
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Ensures efficient testing of FeNO as it is a simple tool for the diagnosis, screening & monitoring of Asthma patients
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Subscribe To Our Newsletter & Stay Updated
